We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
As part of pharmaphorum’s eye-on-innovation series of interviews, Richard Staines speaks to Michael Sierra, Vice President of LEO Pharma’s Science and Tech Hub, about how the firm plans to chan
The concept of evidence-based medicine (EBM), coined by Gordon Guyatt in 1992 to refer to the use of modern, best evidence in making decisions about the care of individual patients
